[go: up one dir, main page]

WO2006034463A3 - Complement a base de plantes permettant de favoriser la perte de poids - Google Patents

Complement a base de plantes permettant de favoriser la perte de poids Download PDF

Info

Publication number
WO2006034463A3
WO2006034463A3 PCT/US2005/034195 US2005034195W WO2006034463A3 WO 2006034463 A3 WO2006034463 A3 WO 2006034463A3 US 2005034195 W US2005034195 W US 2005034195W WO 2006034463 A3 WO2006034463 A3 WO 2006034463A3
Authority
WO
WIPO (PCT)
Prior art keywords
weight loss
support weight
herbal supplement
herbal
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/034195
Other languages
English (en)
Other versions
WO2006034463A2 (fr
Inventor
Michael Yatcilla
Kim Krumhar
Janice Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Herbalife International Inc
Original Assignee
Herbalife International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Herbalife International Inc filed Critical Herbalife International Inc
Publication of WO2006034463A2 publication Critical patent/WO2006034463A2/fr
Publication of WO2006034463A3 publication Critical patent/WO2006034463A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A61K36/5777—Theobroma, e.g. cocao or cocoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Cette invention concerne des combinaisons chimiques et à base de plantes permettant de favoriser la perte de poids. Les plantes contenues dans la composition peuvent comprendre, entre autres, le thé vert, le gingembre, le cacao et la yerba mate. D'autres produits chimiques contenus dans la composition décrite dans cette invention peuvent comprendre, entre autres, la caféine et un sel de calcium pharmaceutiquement acceptable.
PCT/US2005/034195 2004-09-23 2005-09-22 Complement a base de plantes permettant de favoriser la perte de poids Ceased WO2006034463A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61242604P 2004-09-23 2004-09-23
US60/612,426 2004-09-23

Publications (2)

Publication Number Publication Date
WO2006034463A2 WO2006034463A2 (fr) 2006-03-30
WO2006034463A3 true WO2006034463A3 (fr) 2006-05-11

Family

ID=35613696

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/034195 Ceased WO2006034463A2 (fr) 2004-09-23 2005-09-22 Complement a base de plantes permettant de favoriser la perte de poids

Country Status (2)

Country Link
US (1) US7329419B2 (fr)
WO (1) WO2006034463A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0520917D0 (en) * 2005-10-14 2005-11-23 Zumbe Albert Chocolate based appetite suppressant
JP5179032B2 (ja) * 2006-09-15 2013-04-10 株式会社ノエビア 痩身用組成物
JP5179033B2 (ja) * 2006-09-15 2013-04-10 株式会社ノエビア 痩身用組成物
US20090274722A1 (en) * 2007-01-29 2009-11-05 Ligums John E Therapeutic Composition for the Treatment of BPH and ED
CN100584207C (zh) * 2007-06-18 2010-01-27 周华 藿香马黛茶
US8227013B2 (en) * 2007-06-29 2012-07-24 Vijaya Nair Dietary nutritional supplements for healthcare
US8563066B2 (en) * 2007-12-17 2013-10-22 New World Pharmaceuticals, Llc Sustained release of nutrients in vivo
US9757346B2 (en) * 2008-09-03 2017-09-12 Volant Holdings Gmbh Compositions and methods for treating insulin resistance and non-insulin dependent diabetes mellitus (type II diabetes)
AU2009306592B2 (en) * 2008-10-20 2013-05-23 Unilever Global Ip Limited An antimicrobial composition
WO2011003705A1 (fr) * 2009-07-06 2011-01-13 Unilever Nv Produit alimentaire contenant deux sections qui contiennent un composé de goût amer à différentes concentrations, et procédé pour réduire l'amertume employant ledit produit alimentaire
CA2801143C (fr) 2009-09-24 2017-09-26 Unilever Plc Agent desinfectant comprenant de l'eugenol, du terpineol et du thymol
US20140294951A1 (en) * 2011-10-26 2014-10-02 Joseph M. Fayad Oral formulations mimetic of Roux-en-Y gastric bypass actions on the ileal brake; Compositions, methods of treatment, diagnostics and systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and T2D
US20130273154A1 (en) * 2011-03-02 2013-10-17 Joseph M. Fayad Oral formulations Mimetic of Roux-en-Y gastric bypass actions on the ileal brake; Compositions, Methods of Treatment, Diagnostics and Systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hpperlipidemia, and type 2 diabetes
US8241680B2 (en) 2010-06-30 2012-08-14 Rock Creek Pharmaceuticals, Inc. Nutraceutical product containing anatabine and yerba maté
MX2013006435A (es) 2010-12-07 2013-07-03 Unilever Nv Composicion para cuidado oral.
US9144556B2 (en) * 2011-01-21 2015-09-29 Lion Corporation Composition for promoting lipolysis
AU2012223528A1 (en) 2011-03-02 2013-10-24 Joseph M. Fayad Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a Hepatitis C virus infection
HK1199733A1 (en) 2011-08-29 2015-07-17 Philip Morris Products S.A. Products for anti-inflammation support
US9693941B2 (en) 2011-11-03 2017-07-04 Conopco, Inc. Liquid personal wash composition
EP2782550A2 (fr) * 2011-11-25 2014-10-01 Unilever N.V. Composition de soin oral comprenant un polyphénol
FR2985425A1 (fr) * 2012-01-10 2013-07-12 Sederma Sa Nouvelle utilisation de la zerumbone
CN103349275A (zh) * 2013-02-01 2013-10-16 福建省汉堂生物制药股份有限公司 一种绿茶保健品及其制备方法
CA3092802A1 (fr) * 2018-03-05 2019-09-12 Laila Nutraceuticals Compositions synergiques a base d'herbes pour le traitement de l'obesite et du surpoids
CN114340398A (zh) * 2019-09-24 2022-04-12 雀巢产品有限公司 甘草及防止lc-pufa氧化
EP4041269A1 (fr) * 2019-10-10 2022-08-17 Zobrius Pharma AS Composition anti-gueule de bois améliorée, sa préparation et ses utilisations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020164387A1 (en) * 2001-02-12 2002-11-07 Kaiyuan Wei Herbal composition and method for controlling body weight and composition
US20040077556A1 (en) * 2002-04-22 2004-04-22 Robert Chinery Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010008641A1 (en) * 1998-11-25 2001-07-19 R. Douglas Krotzer Nutritionally active composition for bodybuilding
US20050085454A1 (en) * 2003-10-16 2005-04-21 Natreon Inc. Phenolic antioxidant-chromium complexes for treatment or prevention of type 2 diabetes or glucose intolerance
AU2005240125A1 (en) * 2004-04-30 2005-11-17 New Hc Formulations Ltd. Weight loss composition and method of inducing weight loss

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020164387A1 (en) * 2001-02-12 2002-11-07 Kaiyuan Wei Herbal composition and method for controlling body weight and composition
US20040077556A1 (en) * 2002-04-22 2004-04-22 Robert Chinery Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Xenadrine EFX; Product Profile (More Info)", INTERNET ARTICLE, 6 August 2004 (2004-08-06), XP002364580, Retrieved from the Internet <URL:http://web.archive.org/web/20040806054855/http://www.cytodyne.com/products.html> [retrieved on 20060126] *
ANONYMOUS: "Xenadrine NRG; Product Profile (More Info)", INTERNET ARTICLE, 6 August 2004 (2004-08-06), XP002364582, Retrieved from the Internet <URL:http://web.archive.org/web/20040806054855/http://www.cytodyne.com/products.html> [retrieved on 20060126] *
NASIR J M ET AL: "Exercise-induced syncope associated with QT prolongation and ephedra-free Xenadrine", MAYO CLINIC PROCEEDINGS 2004 UNITED STATES, vol. 79, no. 8, August 2004 (2004-08-01), pages 1059 - 1062, XP009060456, ISSN: 0025-6196 *
SALDANA M D A ET AL: "Extraction of Purine Alkaloids from Mate (Ilex paraguariensis) Using Supercritical CO2", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 47, no. 9, 27 August 1999 (1999-08-27), pages 3804 - 3808, XP002984368, ISSN: 0021-8561 *

Also Published As

Publication number Publication date
US20060165820A1 (en) 2006-07-27
WO2006034463A2 (fr) 2006-03-30
US7329419B2 (en) 2008-02-12

Similar Documents

Publication Publication Date Title
WO2006034463A3 (fr) Complement a base de plantes permettant de favoriser la perte de poids
TWI350756B (en) 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
WO2007109802A3 (fr) Extraits de l&#39;espèce de thé vert et méthodes de préparation de ces derniers
SG121100A1 (en) Method of preparing tea extract and tea flavor
IL181200A0 (en) Natural extract containing xanthohumol, and method for the production thereof and products produced therefrom
IL180682A0 (en) N-hydroxamide derivatives, their preparation and use
IL180108A (en) Sulfamate and Sulfamide Derivatives, Pharmaceutical Preparations Containing Them, Processes for their Preparation
WO2005123032A8 (fr) Compositions de soins capillaires et procedes associes
WO2005039493A3 (fr) Composition aux herbes permettant a un individu de controler son poids
IL182054A0 (en) Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
SG120306A1 (en) Package green tea drink
PL1945040T3 (pl) Sposób wytwarzania ekstraktu kawowego i ekstrakt tak otrzymany
EP1841404A4 (fr) Composition ameliorant l&#39;etat de la peau comprenant un extrait de vaccinium uliginosum et procede de preparation de celle-ci
PL1584240T3 (pl) Kompozycje herbat ziołowych wzbogaconych suchymi wyciągami roślinnymi
PL2066186T3 (pl) Wyciąg z zielonej herbaty, zwłaszcza do stosowania jako funkcjonalny środek spożywczy, uzupełniający środek spożywczy lub odpowiedni dodatek spożywczy, zastosowanie takiego wyciągu z zielonej herbaty oraz sposób jego wytwarzania
EP2003988A4 (fr) Composition à base d&#39;extraits de plantes naturelles pour la prévention et le traitement d&#39;hyperlipidémie et de l&#39;accident cérébrovasculaire, thé naturel en contenant comme principe actif et procédé de préparation du thé naturel
WO2005070183A3 (fr) Creme glacee et preparations de creme glacee contenant du maltitol
TWI371245B (en) Packaged oolong tea beverage
WO2006041808A3 (fr) Inhibiteurs de la tafi et leur utilisation pour traiter la fibrose pulmonaire
GB0409846D0 (en) Tea extracts
GB2410172B (en) Chocolate flavour extract
WO2008082575A3 (fr) Utilisation de saccharides dans l&#39;extraction du thé ou de plantes herbacées
EP1813288A4 (fr) Préparation thérapeutique, formule thérapeutique, et formule combinée
WO2004105679A3 (fr) Utilisation d&#39;une composition nutritionnelle dans le traitement de l&#39;hypertension
WO2007017646A3 (fr) Composition antimalarienne

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase